Investigation of Protein Biomarkers of Prostate Cancer

This study has been completed.

Sponsor:

Information provided by:

University of New Mexico

ClinicalTrials.gov Identifier:

NCT00323180

First received: May 5, 2006

Last updated: January 6, 2010

Last verified: November 2009

Purpose

This study is looking at biomarkers in prostate cancer.

Condition
Prostate Cancer

Study Type:	Observational
Study Design:	Time Perspective: Prospective
Official Title:	Investigation of Protein Biomarkers of Prostate Cancer

Resource links provided by NLM:

MedlinePlus related topics: Cancer Prostate Cancer

U.S. FDA Resources

Further study details as provided by University of New Mexico:

Study Start Date:	August 2005
Study Completion Date:	February 2009
Primary Completion Date:	February 2009 (Final data collection date for primary outcome measure)

Detailed Description:

To establish primary culture of epithelial cells isolated from prostatectomy samples
To study biomarkers in prostate cancer

Eligibility

Study Population

Patients with prostate cancer

Criteria

Inclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00323180

Locations

United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131

Sponsors and Collaborators

University of New Mexico

Investigators

Principal Investigator:

Marco Bisoffi

University of New Mexico

More Information

No publications provided

Responsible Party:	Marco Bisoffi; Principal Investigator, Universtiy of New Mexico
ClinicalTrials.gov Identifier:	NCT00323180 History of Changes
Other Study ID Numbers:	HRRC 03-376
Study First Received:	May 5, 2006
Last Updated:	January 6, 2010
Health Authority:	United States: Institutional Review Board

Additional relevant MeSH terms:

Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site

Neoplasms
Genital Diseases, Male
Prostatic Diseases

ClinicalTrials.gov processed this record on May 19, 2013